0001209191-23-031008.txt : 20230519
0001209191-23-031008.hdr.sgml : 20230519
20230519162718
ACCESSION NUMBER: 0001209191-23-031008
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230517
FILED AS OF DATE: 20230519
DATE AS OF CHANGE: 20230519
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COUGHLIN TIMOTHY
CENTRAL INDEX KEY: 0001376043
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37378
FILM NUMBER: 23940534
MAIL ADDRESS:
STREET 1: 339 NORTH GRANADOS AVE
CITY: SOLANA BEACH
STATE: CA
ZIP: 92075
FORMER NAME:
FORMER CONFORMED NAME: Coughlin Timothy P
DATE OF NAME CHANGE: 20060919
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: aTYR PHARMA INC
CENTRAL INDEX KEY: 0001339970
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203435077
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 10240 SORRENTO VALLEY ROAD
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 8587318389
MAIL ADDRESS:
STREET 1: 10240 SORRENTO VALLEY ROAD
STREET 2: SUITE 300
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0407
4
2023-05-17
0
0001339970
aTYR PHARMA INC
LIFE
0001376043
COUGHLIN TIMOTHY
C/O ATYR PHARMA, INC.
10240 SORRENTO VALLEY ROAD, SUITE 300
SAN DIEGO
CA
92121
1
0
0
0
0
Common Stock
2023-05-17
5
G
0
E
6000
0.00
D
0
D
Common Stock
2023-05-17
5
G
0
E
6000
0.00
A
6000
I
See Footnote
Stock Option (right to buy)
2.52
2023-05-17
4
A
0
12000
0.00
A
2033-05-17
Common Stock
12000
12000
D
These shares are owned by the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person and his spouse serve as co-trustees of the Coughlin Family Trust u/a DTD 12/07/2006. The Reporting Person may be deemed to be the beneficial owner of the securities held by the Coughlin Family Trust u/a DTD 12/07/2006.
The option, granted pursuant to the Issuer's non-employee director compensation policy, vests in full on the earlier of (i) May 17, 2024 or (ii) the Issuer's 2024 Annual Meeting of Stockholders, subject to the Reporting Person's continued service on the Board of Directors.
/s/ Nancy E. Denyes, as Attorney-in-Fact
2023-05-19